- Oral BG-12 in Multiple Sclerosis Reply2013 | First Faculty of Medicine
- Oral BG-12 in relapsing-remitting MS2009 | First Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis2012 | First Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | Second Faculty of Medicine
- Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM2013 | First Faculty of Medicine
- Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study2015 | First Faculty of Medicine
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study2013 | First Faculty of Medicine